Welcome to the ALDA Pharmaceuticals Hub on AGORACOM

(Edit this message through the "fast facts" section)

Free
Message: It appears we need

Yes the time is near, But this will really push it when we get this news (Paragraph: RETAIL Products)

November 15, 2007

APH: TSX-V

LETTER TO THE SHAREHOLDERS OF ALDA PHARMACEUTICALS CORP.

It has been a very eventful year for ALDA Pharmaceuticals Corp. As described below, during 2007, the

Company arranged three financings, received allowances for its patent in three jurisdictions, started the

process of introducing its products to consumers, secured marketing and manufacturing rights in China,

started testing the T36® formulation for therapeutic markets and observed the share price increase by nearly

10-fold. In the remaining six weeks of the year, we may see patents issued in China, the US and Australia,

approval from Health Canada for a new antiseptic hand cleanser and progress on the registration of ALDA’s

securities in the US. Here are the highlights of our year.

Financings in 2007

In April this year, ALDA arranged a $500,000 private placement which became over subscribed and

closed in June with a total of $800,000 being raised. While the private placement was in progress,

ALDA shares saw unprecedented trading and over 8 million shares traded in a single day. Since then,

the Company has seen much improved liquidity with an average of over 450,000 shares trading daily

over the last 100 days.

In July, a $240,000 private placement was arranged. This private placement also quickly became

oversubscribed and the Company had to turn away a number of people who had wanted to participate.

This situation was repeated with a private placement for $525,000 arranged in October. The

documentation for this financing has now been filed with the TSX Venture Exchange for approval. Once

this placement is closed the company will have over $1.5 million in cash. The amount of cash on hand

was augmented by a number warrants and options being exercised this year. The company is now in a

position to pursue a number of initiatives that are described below.

Retail Products

Cowie and Fox, working with Group 270, have now created a new identity and logo for the retail

products and have started on the marketing program that will be used to introduce the products to

consumers. A trademark application has been filed in Canada for the new name and the Company has

six months after the date of that application to file for international trademarks. Details on the new name

and marketing materials will be disclosed at the time the products are launched.

The new identity will also apply to the new antiseptic hand cleanser that is in the process of being

registered with Health Canada as announced by the company on October 30, 2007. This product is

expected to have an advantage in the market because an antiseptic is more powerful than a sanitizer and

kills a wider variety of infectious organisms. Packaged with T36® Disinfectant, the new antiseptic hand

 

Share
New Message
Please login to post a reply